Schmid R A, Yamashita M, Ando K, Tanaka Y, Cooper J D, Patterson G A
Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, Barnes Hospital, St. Louis 63110, USA.
Ann Thorac Surg. 1996 Mar;61(3):949-55. doi: 10.1016/0003-4975(95)01182-X.
Depletion of neutrophils (PMNs) and inhibition of PMN endothelial adhesion ameliorate post-ischemic lung reperfusion injury. Lidocaine reduces PMN adhesion to endothelial surfaces in vivo, and inhibits upregulation of PMN-CD11b/CD18 (Mac-1) in vitro. We evaluated the effect of lidocaine on reperfusion injury, PMN adhesion, and PMN migration in preserved lung allografts.
Donor lungs were flushed with modified Euro-Collins solution (4 degrees C) after prostaglandin E1 administration (250 micrograms), inflated with 550 mL (inspired oxygen fraction = 1.0), and stored for 24 hours at 1 degree C. Left lung allotransplantation was performed in 13 mongrel dogs. Immediately after reperfusion the recipient right pulmonary artery and bronchus were ligated to permit assessment of allograft function during a 6-hour postreperfusion period. Allograft gas exchange (every 15 minutes) and hemodynamics (every 60 minutes) were assessed. Peripheral blood PMN CD11b expression was determined by flow cytometry. After sacrifice allograft bronchoalveolar lavage fluid PMN count and allograft tissue myeloperoxidase activity were measured. Two groups were studied: In group I (n = 8) lidocaine hydrochloride was added to the donor flush (20 mg/L) solution. In addition lidocaine was given to the recipient at the time of thoracotomy (intravenous bolus of 4 mg/kg) followed by a continuous infusion of 4 mg/kg/h during implantation and the assessment period. Three dogs that did not reach effective lidocaine blood levels at the time of reperfusion (3 to 4 micrograms/mL) were excluded from analysis. Group II animals (n = 5) received no lidocaine.
Gas exchange in group I was superior throughout the assessment period (p < 0.05). Bronchoalveolar lavage fluid PMN count in group I was reduced (0.36 x 10(6)PMN/mL versus 6.2 x 10(6) PML/mL; p < 0.03). Group I allograft myeloperoxidase activity was 0.17 U/mg/min compared with 0.28 U/mg/min in group II (p < 0.01). In lidocaine-treated animals PMN CD11b expression was maintained at basal levels 2 hours after reperfusion, compared with group II, in which upregulation of CD11b was observed. Lower lobe wet/dry ratio was not different in the two groups.
Our observations indicate that lidocaine reduces reperfusion injury and inhibits PMN adhesion and subsequent migration to the lung allograft.
中性粒细胞(PMN)的消耗以及PMN与内皮细胞黏附的抑制可改善缺血后肺再灌注损伤。利多卡因可在体内降低PMN与内皮表面的黏附,并在体外抑制PMN-CD11b/CD18(Mac-1)的上调。我们评估了利多卡因对保存的肺移植中再灌注损伤、PMN黏附及PMN迁移的影响。
给予前列腺素E1(250微克)后,用改良的Euro-Collins溶液(4℃)冲洗供体肺,充入550毫升气体(吸入氧分数=1.0),并在1℃下保存24小时。对13只杂种犬进行左肺同种异体移植。再灌注后立即结扎受体右肺动脉和支气管,以便在再灌注后6小时内评估移植肺功能。评估移植肺气体交换(每15分钟一次)和血流动力学(每60分钟一次)。通过流式细胞术测定外周血PMN CD11b表达。处死后,测量移植肺支气管肺泡灌洗液PMN计数和移植肺组织髓过氧化物酶活性。研究分为两组:I组(n=8),将盐酸利多卡因添加到供体冲洗液(20毫克/升)中。此外,在开胸时给受体静脉推注4毫克/千克利多卡因,随后在植入和评估期间持续输注4毫克/千克/小时。3只在再灌注时未达到有效利多卡因血药浓度(3至4微克/毫升)的犬被排除在分析之外。II组动物(n=5)未接受利多卡因。
在整个评估期内,I组的气体交换情况更好(p<0.05)。I组支气管肺泡灌洗液PMN计数降低(0.36×10⁶个PMN/毫升对6.2×10⁶个PML/毫升;p<0.03)。I组移植肺髓过氧化物酶活性为0.17单位/毫克/分钟,而II组为0.28单位/毫克/分钟(p<0.01)。在利多卡因治疗的动物中,再灌注2小时后PMN CD11b表达维持在基础水平,而II组则观察到CD11b上调。两组下叶湿/干比无差异。
我们的观察结果表明,利多卡因可减轻再灌注损伤,并抑制PMN黏附及随后向肺移植的迁移。